Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuropeptide S is a 20-amino acid peptide neurotransmitter that acts as the endogenous ligand for the Neuropeptide S receptor (NPSR), a G protein-coupled receptor. NPS is expressed primarily in a restricted neuronal population in the brainstem (especially near the locus coeruleus), while its receptor is widely expressed throughout the CNS (including the amygdala, subiculum, cortex), and peripherally in tissues such as the airway epithelium. NPS signaling promotes arousal, enhances memory during the consolidation phase, reduces anxiety, and modulates fear extinction. Polymorphisms in NPSR are clinically linked to roles in asthma, anxiety disorders, and rare sleep syndromes. Pharmacologic manipulation of NPSR is under investigation for potential treatments of anxiety, cognitive dysfunction, and inflammatory conditions.
NPS activates NPSR, a G protein-coupled receptor, promoting cAMP signaling, Ca²⁺ mobilization, and neurotransmitter release (including enhanced glutamatergic transmission). NPSR antagonists block receptor function and consequently NPS-mediated effects.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide S (NPS).